|
WIRB News
Review of Individual Research Locations
WIRB Launches New Authenticated Web Site February 4, 2008
New, Simplified Text of California Experimental Subjects’ Bill of
Rights
Additions to the Certificate of Approval
New Online Submission Feature
Pediatric Assent Changes
Changes to WIRB's Consent Form Approval Stamp
WIRB Announces Full Reaccreditation
Review of Individual Research Locations
Beginning April 1, 2008, Certificates of Approval issued by WIRB will cite the individual
research location addresses that have been approved for the investigator.
The research site information required by WIRB at initial review remains the same.
However, in order to conduct the review of changes to research locations after initial
review, WIRB requires additional information about any new locations where subjects will be
seen. WIRB’s Change in Research Submission Form has been updated to include a “Change in Research –
Additional Site Form” that solicits information about new research location(s).
Any time an investigator provides WIRB with updated research site information (via a letter,
revised box 3 of the 1572, etc.) for an open research study where subjects are seen, a “Change in
Research - Additional Site Form” must be completed and provided to WIRB for each additional or
changed site. This form is not required for changes to administrative locations (sites where no
subjects are seen). The Board will review the information and, if approved, issue a Certificate of
Approval citing approval of the new location(s).
If a consent form has been approved for the research, WIRB will also issue an updated consent form
that reflects the new location(s).
Copies of the “Change in Research – Additional Site Form” may be downloaded from the Download Forms
page of the WIRB website (www.wirb.com), or you may request a copy via fax, e mail or postal mail by
contacting a WIRB Client Service Representative at 1-800-562-4789 or e-mailing
clientservices@wirb.com.
Thank you for using WIRB and for joining us in our pursuit of continuous improvement.
WIRB Launches New Authenticated
Web Site February 4, 2008
WIRB is pleased to announce WIRBNet, an on-line information portal designed to provide
expanded submission detail, enhanced tracking features and the secure download of
approval documents. WIRBNet liberates users from the limits of time zones, phone
calls and e-mails.
In order to access confidential research review information, users are given a personal
account with a user name and password.
Once logged on, users may select from the following options:
- WIRBNet Tracking (to view the details of research in progress and research pending
review)
- Online Submissions (to allow the secure upload of review materials to WIRB)
- View Rights Account Management (to grant view rights to study coordinators and other
research-related staff who need access to the information)
“WIRBNet Tracking” presents a list of the protocols to which the user is associated.
Users may then click on a protocol to see detail about specific investigator reviews,
continuing review report forms, protocol variances, and site adverse event reporting,
all of which may be printed or exported to an Excel spreadsheet.
“Now you and your study team can have real time access to current information about
research submissions to WIRB whenever you might need it.
Simplified Text of California
Experimental Subjects’ Bill of Rights
In order to help sites in California comply with California State regulations, WIRB
attaches the California Experimental Subject’s Bill of Rights to consent forms for
sites in California. Up until recently, the text WIRB included was copied directly
from the applicable portion of California’s Health & Safety Code.
However, the Health & Safety Code does not require subjects be provided with the
information verbatim as outlined in the statute, so WIRB recently developed a simplified
version of the text. Before adopting it, WIRB presented it to the California Attorney
General. The Attorney General provided feedback, and WIRB has now adopted language
that is acceptable to both the members of WIRB and the California Attorney General.
Beginning in September 2007, the simplified language will be added to new consent
forms for sites in California. The text in existing, approved consent forms will
not be changed.
Additions to the Certificate
of Approval
In July 2007, WIRB added new information to its Certificates of Approval.
All Certificates now display the Site Status Reporting frequency and Continuing
Review Frequency:
The Continuing Review field indicates the frequency with which the Board conducts
Continuing Study Review. Click here
for more information about WIRB’s study renewal processes and requirements.
The Site Status Reporting field indicates how often the site is required to complete
a Continuing Review Report form. Click here
for more information about WIRB’s continuing review reporting requirements.
Certificates of Approvals for WIRB’s Canadian panel (Panel
10) also include two additional fields:
- A field indicating that panel 10 is WIRB’s Canadian Panel:
- A set of attestation statements congruent with those in Health Canada’s Research
Ethics Board Attestation form (REBA):
In respect of the identified clinical trial, I certify, as chair of this Research
Ethics Board that:
- The membership of this Research Ethics Board complies with the membership requirements
for Research Ethics Boards defined in Part C Division 5 of the Food and Drug Regulations,
Part 4 of the Natural Health Products Regulations, and the Tri-Council
Policy Statement (TCPS);
- This Research Ethics Board carries out its functions in a manner consistent with
Good Clinical Practices; and
- This Research Ethics Board has reviewed and approved the clinical trial protocol
and informed consent form for the trial which is to be conducted by the qualified
investigator named above at the specified clinical trial site. This approval and
the views of this Research Ethics Board have been documented in writing.
Because the content of WIRB’s Certificate of Approval for Canadian sites is
now congruent with the content of Health Canada’s Research Ethics Board Attestation
form, sites are no longer required to submit REBA forms with their review requests
and WIRB will no longer complete REBA forms for new review requests.
New Online Submission Feature
WIRB is pleased to announce a new Online Submission feature of our WIRB.com website.
Many of our customers have asked for a better way to transmit documents to us. The
Online Submission feature will let you upload documents to us through a safe and
secure process.
To use this feature, simply click the ‘Online Submission’ button on
the WIRB.com webpage and follow the easy directions. You can access the site at
www.wirb.com
The general steps are:
- Select the type of submission you wish to make
- Upload your individual documents to the site
- Complete the ‘Submitter Information’ page.
- Click the ‘Finalize Submission’ button
- Receive your confirmation page (and email) that includes your Submission Number.
The confirmation means that WIRB has received and can begin processing your submission.
You can reference your Submission Number in any communication with our Client Services
team. Note that your confirmation email can serve as an official “Acknowledgement
of Receipt.” You will still receive a separate tracking number once we create
the work order to review your submission.
We are pleased to provide this new service to you, and we hope that this –
and other initiatives we are working on – help reduce the time needed for
IRB review.
Please let us know if you have any questions, comments or suggestions.
Pediatric Assent Changes
In response to suggestions from WIRB’s pediatric panel chairman, and several
IRB chairs at prominent children’s research centers around the country, the
Board is implementing a new approach to obtaining and documenting child assent.
The new approach to assent would eliminate the requirement to obtain signatures
of minors on the consent form or an assent form. Instead, the current signature
lines for minors will be replaced with a set of statements to be certified by the
person conducting the assent discussion, verifying the minor subject’s understanding
and assent. Below is an example of the proposed assent section.
This approach to assent is widely used at children’s hospitals around the
country and meets the regulatory requirements for documentation of assent under
21 CFR 50.55(g) and 45 CFR 46.408(e). Please note that this does not change in any
way the requirement to obtain assent. Rather, it only changes the manner in which
the assent is documented.
The Board will be implementing this new approach to obtaining and documenting assent
from minors in the near future. This new approach will be applied to new research
only; unless specifically requested to do so, we will not apply it retroactively.
We would like to alert you to this change in process at WIRB, and would appreciate
any feedback or concerns on the proposed process. Please address your questions
and concerns to David Forster JD, Vice President, Compliance at 360-252-2428.
Below is a copy of the assent section that would be incorporated into the signature
section of the main consent form. When a separate assent form is submitted to WIRB,
the Board will consider whether to modify the assent form into an age appropriate
information sheet to be provided to the minor to aid in the assent discussion.
ASSENT SECTION:
Statement of person conducting assent discussion:
- I have explained all aspects of the research to the subject to the best of his or
her ability to understand.
- I have answered all the questions of the subject relating to this research.
- The subject agrees to be in the research.
- I believe the subject’s decision to enroll is voluntary.
- The study doctor and study staff agree to respect the subject’s physical or
emotional dissent at any time during this research when that dissent pertains to
anything being done solely for the purpose of this research.
__________________________ ____________
Signature of Person Conducting / Date
Assent Discussion
Statement of Parent/Guardian:
My child appears to understand the research to the best of his or her ability and
has agreed to participate.
______________________ ______________
Signature of Parent/Guardian / Date
Changes to WIRB's Consent
Form Approval Stamp
This month WIRB's approval stamp is slimming down. Consent form approval stamps
will no longer specify "Olympia, WA."
Our headquarters continue to be located in Olympia, but our increasing review of
international research has prompted us to eliminate the Olympia reference from our
approval stamps.
Though it is a small change, the elimination also contributes to our overall effort
to keep our consent forms as concise as possible for the subjects who read them.
WIRB Announces Full Reaccreditation
WIRB is pleased to announce that the Association for the Accreditation of Human
Research Protection Programs (AAHRPP) has renewed WIRB’s fully accredited
status.
The Association for the Accreditation of Human Research Protection Programs (AAHRPP)
“seeks not only to ensure compliance, but to raise the bar in human research
protection by helping institutions reach performance standards that surpass the
threshold of state and federal requirements.” On April 28, 2003, WIRB was
the first independent IRB to be issued full accreditation by AAHRPP.
Every three years accredited institutions must re-submit an accreditation application
to request renewal of their accreditation.
Click the link below to view previous WIRB News items:
WIRB News Archives
|